Cargando…

Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer

Heterogeneous ribonucleoprotein K (hnRNP K) is a member of the hnRNP family which has several different cellular roles including transcription, mRNA shuttling, RNA editing and translation. Several reports implicate hnRNP K having a role in tumorigenesis, for instance hnRNP K increases transcription...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carpenter, B, McKay, M, Dundas, S R, Lawrie, L C, Telfer, C, Murray, G I
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2006
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360539/ https://www.ncbi.nlm.nih.gov/pubmed/16953238 http://dx.doi.org/10.1038/sj.bjc.6603349

Ejemplares similares

KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer
por: Alshareeda, A T, et al.
Publicado: (2015)

Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer
por: Barboro, P, et al.
Publicado: (2009)

Nuclear localisation of LASP-1 correlates with poor long-term survival in female breast cancer
por: Frietsch, J J, et al.
Publicado: (2010)

Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study
por: Lessard, L, et al.
Publicado: (2005)

Characterisation and protein expression profiling of annexins in colorectal cancer
por: Duncan, R, et al.
Publicado: (2008)

Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer
por: Preuss, S F, et al.
Publicado: (2008)

Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma
por: Wallard, M J, et al.
Publicado: (2006)

Impact of differential cyclin D1 expression and localisation in prostate cancer
por: Comstock, C E S, et al.
Publicado: (2007)

RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomas
por: Deb, S, et al.
Publicado: (2014)

Localisation of renin-angiotensin system (RAS) components in breast
por: Tahmasebi, M, et al.
Publicado: (2006)

Reply: Evidence for heterogeneous nuclear ribonucleoprotein k over expression in oral squamous cell carcinoma
por: Carpenter, B, et al.
Publicado: (2007)

Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer
por: Cuzick, J, et al.
Publicado: (2013)

Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation
por: Chugh, Seema, et al.
Publicado: (2016)

The clinical significance of splice variants and subcellular localisation of survivin in non-small cell lung cancers
por: Nakano, J, et al.
Publicado: (2008)

Tissue level, activation and cellular localisation of TGF-β1 and association with survival in gastric cancer patients
por: Hawinkels, L J A C, et al.
Publicado: (2007)

High expression of RelA/p65 is associated with activation of nuclear factor-κB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis
por: Weichert, W, et al.
Publicado: (2007)

Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisation
por: Grunewald, T G P, et al.
Publicado: (2007)

Relation between outcomes and localisation of p-mTOR expression in gastric cancer
por: Murayama, T, et al.
Publicado: (2009)

Expression and localisation of Akt-1, Akt-2 and Akt-3 correlate with clinical outcome of prostate cancer patients
por: Le Page, C, et al.
Publicado: (2006)

Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?
por: Margetts, Jane, et al.
Publicado: (2018)

Localisation pattern of Foxp3(+) regulatory T cells is associated with clinical behaviour in gastric cancer
por: Mizukami, Y, et al.
Publicado: (2008)

Tissue microarray analysis of human FRAT1 expression and its correlation with the subcellular localisation of β-catenin in ovarian tumours
por: Wang, Y, et al.
Publicado: (2006)

Aberrant methylation of SPARC in human lung cancers
por: Suzuki, M, et al.
Publicado: (2005)

A prognostic profile of hypoxia-induced genes for localised high-grade soft tissue sarcoma
por: Aggerholm-Pedersen, Ninna, et al.
Publicado: (2016)

High expression of TROP2 correlates with poor prognosis in pancreatic cancer
por: Fong, D, et al.
Publicado: (2008)

Different cellular p16(INK4a) localisation may signal different survival outcomes in head and neck cancer
por: Zhao, N, et al.
Publicado: (2012)

Serum amyloid A is elevated in the serum of lung cancer patients with poor prognosis
por: Cho, W C S, et al.
Publicado: (2010)

Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease
por: Clark, S E, et al.
Publicado: (2011)

Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis
por: Arrieta, O, et al.
Publicado: (2008)

Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer
por: Sørensen, K D, et al.
Publicado: (2013)

Arpin downregulation in breast cancer is associated with poor prognosis
por: Lomakina, Maria E, et al.
Publicado: (2016)

Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer
por: Larsson, A, et al.
Publicado: (2011)

Two-marker protein profile predicts poor prognosis in patients with early rectal cancer
por: Zlobec, I, et al.
Publicado: (2008)

Tumour-associated CD66b(+) neutrophil count is an independent prognostic factor for recurrence in localised cervical cancer
por: Carus, A, et al.
Publicado: (2013)

Changes in subcellular localisation of MI-ER1α, a novel oestrogen receptor-α interacting protein, is associated with breast cancer progression
por: McCarthy, P L, et al.
Publicado: (2008)

EIF5A2 predicts outcome in localised invasive bladder cancer and promotes bladder cancer cell aggressiveness in vitro and in vivo
por: Wei, J-H, et al.
Publicado: (2014)

Reduced expression of bone morphogenetic protein receptor IA in pancreatic cancer is associated with a poor prognosis
por: Voorneveld, P W, et al.
Publicado: (2013)

Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis
por: Goos, J A C M, et al.
Publicado: (2013)

Expression of N-acetylglucosaminyltransferase V in endometrial cancer correlates with poor prognosis
por: Yamamoto, E, et al.
Publicado: (2007)

Aberrant CDKN1A transcriptional response associates with abnormal sensitivity to radiation treatment
por: Badie, C, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_b551fb3bk9g3s23kv2rb1pvspn